Skip to content
HealthPBS News Hour - The Latest

FDA issues vision loss warning for GLP-1 drugs

By PBS NewsHour

The Food and Drug Administration issued a new warning on Monday about the risk of vision loss related to popular GLP-1 weight loss and diabetes drugs. Health officials say drugs like Eli Lilly’s Zepbound and Ozempic by Novo Nordisk must add a warning label about the rare disease, which can cause blurred vision or…

Read Original Article

More in Health

From the blog